Fortive Q3 Revenue Rises 7.8%; Raises 2026 Adjusted EPS Guidance

Fortive reported Q3 2026 revenue of $1.11B, up 7.8% YoY, with adjusted EPS rising 13.2% to $0.77. The company raised its full-year adjusted EPS guidance to $3.10–$3.14. Core revenue growth was 7.2%, with Intelligent Operating Solutions up 9.1% and Advanced Healthcare Solutions up 3.1%. Fortive repurchased 5M shares for $300M during the quarter.

Original reporting
Published Oct 28, 2026, 11:33 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 11:42 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Fortive Q3 Revenue Rises 7.8%; Raises 2026 Adjusted EPS Guidance — source image
Decision brief

The 30-second read

$FTVBullishHigh
01

Why it matters

The combination of revenue growth, higher adjusted EPS, and a raised FY adjusted EPS range is a direct earnings catalyst that can shift valuation multiples and consensus estimates.

02

Market read

Traders can update FY earnings models immediately based on the raised adjusted EPS guidance range and the quarter’s operating improvements.

03

What to watch

Gross margin is not stated, so traders may focus on whether operating leverage is sustainable and whether buybacks (5M shares, ~$300M) materially change per-share earnings quality.

Relevance 9/10Novelty 9/10Timing: reported Oct. 28, 2026, with raised FY adjusted EPS guidance

Background

Fortive is reporting its Q3 2026 results and updating full-year adjusted EPS guidance, including segment performance and share repurchases.

Company-level read

Ticker impact

$FTVBullishHigh confidence
Context

Fortive reported Q3 2026 revenue of $1.11B (+7.8% YoY) and raised full-year adjusted EPS guidance to $3.10–$3.14.

Expected impact

Likely upward pressure as the market reprices FY adjusted EPS expectations around the raised guidance.

Evidence & confidence

The article discloses a fresh quarterly print plus an explicit full-year adjusted EPS guidance increase, which are direct drivers for earnings-model updates.

Market effects

Signals resilience in industrial/engineering services demand and recurring solutions growth, potentially supportive for peers with similar end markets.

Primarily US-listed earnings read-through; limited direct regional spillover beyond industrials sentiment.

Modest global relevance as a single-company earnings and guidance update, not a macro or cross-border policy event.

Counterpoint

Core revenue growth is positive but Advanced Healthcare Solutions segment operating profit declined year over year, which could temper enthusiasm.

Key entities

  • Fortive Corp

    Reported Q3 2026 revenue and adjusted EPS, and raised full-year adjusted EPS guidance; also disclosed share repurchases.

Related articles

$FTVMed

Is Ingersoll Rand A Better Way Than Fortive To Own Industrial Demand?

Fortive (FTV) and Ingersoll Rand (IR) both raised 2026 forecasts. FTV increased adjusted EPS to $3.12, citing strong performance. IR raised revenue growth to 6.3% and EPS to $3.64, attributing it to lower tax rate and share count. FTV has higher margins (63.5%) and focuses on buybacks, while IR emphasizes aftermarket sales and acquisitions, with lower margins (43.1%).

$FTVMed

Mizuho raises Fortive stock price target to $55 on earnings beat

Mizuho raised its price target for Fortive (FTV) to $55 from $51, keeping an Underperform rating. Fortive reported adjusted EPS of $0.77, beating estimates of $0.71, with 13% YoY growth. Core growth was 7.2%, and adjusted EBITDA margin was 30.6%. The company raised its 2026 EPS guidance to $3.10-$3.14. The stock is up 16.5% YTD. Truist also raised its target to $65, citing strong growth and margins.

$FTVHighAI 8/10

Fortive Corp (FTV) (Q3 2026) Earnings Call Highlights: Fifth Straight Quarter

Fortive Corp (FTV) reported Q3 2026 earnings, highlighting a decline in adjusted gross margin to 63% due to product mix. The Advanced Healthcare Solutions segment saw EBITDA margin contract 230 bps. CEO Soroye expressed confidence in long-term growth despite inflationary pressures and a Q4 revenue headwind of $15-$20M. The company is investing in innovation and data center sales, with core growth tracking above 5% for the year.